Hansoh Bio is the U.S.‐based research & development subsidiary of Hansoh Pharma. Our mission is to discover and develop innovative therapies to help patients combat and conquer serious diseases and disorders worldwide. We are supported by our parent company Hansoh Pharma, which is a leading biopharmaceutical company in Asia. Founded in 1995, Hansoh’s rapidly growing workforce of 10,000+ employees, and our fully integrated R&D, manufacturing and commercial capabilities have propelled us into leadership positions across a broad range of therapeutic areas, including CNS, oncology, infectious diseases, and metabolic disorders.